Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015

Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2670CTIDB
  • |
  • Pages: 61
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015" provides data on the Autoimmune Hepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autoimmune Hepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Autoimmune Hepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Autoimmune Hepatitis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Autoimmune Hepatitis 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Autoimmune Hepatitis Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Veloxis Pharmaceuticals A/S 31

Clinical Trial Overview of Veloxis Pharmaceuticals A/S 31

Iltoo Pharma 32

Clinical Trial Overview of Iltoo Pharma 32

Dr. Falk Pharma GmbH 33

Clinical Trial Overview of Dr. Falk Pharma GmbH 33

BioIncept, LLC 34

Clinical Trial Overview of BioIncept, LLC 34

Alfact Innovation 35

Clinical Trial Overview of Alfact Innovation 35

Clinical Trial Overview of Top Institutes / Government 36

Beijing 302 Hospital 36

Clinical Trial Overview of Beijing 302 Hospital 36

Juntendo University School of Medicine 37

Clinical Trial Overview of Juntendo University School of Medicine 37

Mayo Clinic 38

Clinical Trial Overview of Mayo Clinic 38

Rigshospitalet 39

Clinical Trial Overview of Rigshospitalet 39

Tehran University of Medical Sciences 40

Clinical Trial Overview of Tehran University of Medical Sciences 40

The National Institute of Allergy and Infectious Diseases 41

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 41

University of Sao Paulo General Hospital 42

Clinical Trial Overview of University of Sao Paulo General Hospital 42

Five Key Clinical Profiles 43

Appendix 59

Abbreviations 59

Definitions 59

Research Methodology 60

Secondary Research 60

About GlobalData 61

Contact Us 61

Disclaimer 61

Source 61

List of Figures

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Autoimmune Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Autoimmune Hepatitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Autoimmune Hepatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Autoimmune Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 60

List of Tables

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Autoimmune Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Autoimmune Hepatitis Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Autoimmune Hepatitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Autoimmune Hepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Autoimmune Hepatitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Autoimmune Hepatitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Autoimmune Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Veloxis Pharmaceuticals A/S, 2015* 31

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Iltoo Pharma, 2015* 32

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2015* 33

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by BioIncept, LLC, 2015* 34

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfact Innovation, 2015* 35

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing 302 Hospital, 2015* 36

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 37

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 38

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2015* 39

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 40

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 41

Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo General Hospital, 2015* 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Veloxis Pharmaceuticals A/S

Iltoo Pharma

Dr. Falk Pharma GmbH

BioIncept, LLC

Alfact Innovation

Autoimmune Hepatitis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Autoimmune Hepatitis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160900
Site License
USD 5000 INR 321800
Corporate User License
USD 7500 INR 482700

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com